Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
As of: Oct 23, 2026 · 9:49 AM EDT

Evofem Biosciences (EVFM) Gains from Sales and Divestitures (2015 - 2025)

Updated

Evofem Biosciences (EVFM) recorded Gains from Sales and Divestitures of -$20,000 in FY2025, compared with -$734,000 in FY2024.

Analysis

Evofem Biosciences (EVFM) Gains from Sales and Divestitures (2015 - 2025) Analysis & Trends

Starting with FY2013, Evofem Biosciences' Gains from Sales and Divestitures history includes 9 years.

  • The FY2025 figure is the highest annual Gains from Sales and Divestitures since FY2016.
  • Per Business Quant data, EVFM's Gains from Sales and Divestitures was -$734,000 in FY2024, -$2.51 million in FY2023 and -$926,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Evofem Biosciences 878,961.72 878,961.72 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3,000.00
Mar 31, 2025 -17,000.00
Dec 31, 2024 -723,000.00
Jun 30, 2024 -6,000.00
Mar 31, 2024 -5,000.00
Dec 31, 2023 -653,000.00
Dec 31, 2017 -645.00
Mar 31, 2017 -55,705.00
Dec 31, 2016 -3,896.00
Sep 30, 2015 -1.00
Mar 31, 2015 -6,139.00
API Access

Evofem Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=EVFM&period=max&api_key=YOUR_API_KEY